|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Expenses | ||||
| Research and development | ||||
| Selling, general and administrative | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Other income (expense): | ||||
| Interest income | ||||
| Interest expense | ||||
| Other income (expense) | ||||
| Total other income, net | ||||
| Loss before income tax | ||||
| Income tax expense | ||||
| Net loss | ||||
| Other comprehensive income (loss) | ||||
| Foreign currency translation adjustments, net of nil tax | ||||
| Total comprehensive loss | ||||
| Weighted average number of ordinary shares used in per share calculation: | ||||
| Basic (in shares) | ||||
| Diluted (in shares) | ||||
| Net loss per ordinary share | ||||
| Basic (in dollar per share) | ||||
| Diluted (in dollar per share) |
Loading...